Nachrichten zur Jazz Pharmaceuticals plc Aktie

Jazz Pharmaceuticals submits NDA for JZP-258 for cataplexy and excessive daytime sleepiness associated with narcolepsy

The company redeemed its priority review voucher for the NDA submission. JZP-258 is a novel oxybate product candidate with a…

Jazz Pharma Files for FDA Approval of a New Narcolepsy Drug

The companys submitted an application for approval of JZP-258, a treatment for cataplexy and excessive daytime sleepiness (EDS) in patients…

Jazz Pharma submits marketing application for JZP-258

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Jazz Pharma submits NDA for JZP-258

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Jazz Pharmaceuticals Submits New Drug Application for JZP-258 for Cataplexy and Excessive Daytime Sleepiness Associated with Narcolepsy

DUBLIN , Jan. 22, 2020 /PRNewswire/ --   Jazz Pharmaceuticals…

PharmaMar and Jazz Pharmaceuticals Announce the U.S. License Agreement for Lurbinectedin is Effective with the Expiration of the HSR Waiting Period

MADRID and DUBLIN , Jan. 22, 2020 /PRNewswire/ -- PharmaMar (MSE:PHM)…

Jazz Pharmaceuticals receives EU marketing authorisation for Sunosi for excessive daytime sleepiness in adults with narcolepsy or OSA

Sunosi is the first dual-acting dopamine and norepinephrine reuptake inhibitor approved to treat EDS in adults living with narcolepsy or…

Jazz Pharmas Sunosi OKd in Europe

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Jazz Pharmaceuticals Receives EU Marketing Authorisation for Sunosi® (solriamfetol) for Excessive Daytime Sleepiness in Adults with Narcolepsy or Obstructive Sleep Apnea

DUBLIN , Jan. 20, 2020 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that…

Jazz Pharmaceuticals (JAZZ) Presents At 38th Annual J.P. Morgan Healthcare Conference - Slideshow

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

PharmaMars (PHMMF) Management on Conference Call to Discuss Jazz Pharmaceuticals License Agreement for Lurbinectedin in the U.S. - Transcript

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Jazz Pharmaceuticals to Present at the 38th Annual J.P. Morgan Healthcare Conference

DUBLIN , Jan. 6, 2020 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced…

Zacks.com featured highlights include: Lithia Motors, Marathon Petroleum, Meritage Homes, Jazz Pharmaceuticals and Barclays PLC

Zacks.com featured highlights include: Lithia Motors, Marathon Petroleum, Meritage Homes, Jazz Pharmaceuticals and Barclays PLC...…

Are Investors Undervaluing Jazz Pharmaceuticals (JAZZ) Right Now-

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to…

Enrollment underway in study of Jazz Pharmas JZP-458 in blood cancers

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Jazz Pharmaceuticals: Uncertain Sales Outlook Is Not Music To Investors Ears

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Is Jazz Pharmaceuticals (JAZZ) Outperforming Other Medical Stocks This Year-

Is (JAZZ) Outperforming Other Medical Stocks This Year?...…

Jazz Pharma in-licenses lung cancer candidate from PharmaMar

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Pfenex Earns $15 Million Development Milestone Under its Development and License Agreement With Jazz Pharmaceuticals

SAN DIEGO, Dec. 18, 2019 (GLOBE NEWSWIRE) -- Pfenex Inc. (NYSE American: PFNX) today announced that it has…

Should Value Investors Buy Jazz Pharmaceuticals (JAZZ) Stock-

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to…

Zacks.com featured highlights include: Quanta Services, Alexion Pharmaceuticals, Jazz Pharmaceuticals and Changyou.com

Zacks.com featured highlights include: Quanta Services, Alexion Pharmaceuticals, Jazz Pharmaceuticals and Changyou.com...…

Why Has Jazz Pharmas Stock Rallied Nearly 20% In A Month-

Jazz Pharmaceuticals (NASDAQ: JAZZ) is a biopharma company based in Ireland. Almost 75% of companys revenues come from a single…

Jazz Pharmaceuticals, Canon, Advanced Energy Industries, Inphi and Skyworks Solutions highlighted as Zacks Bull and Bear of the Day

Jazz Pharmaceuticals, Canon, Advanced Energy Industries, Inphi and Skyworks Solutions highlighted as Zacks Bull and Bear of the Day...…

Bull of the Day: Jazz Pharma (JAZZ)

Bull of the Day: Jazz Pharma (JAZZ)...…

Jazz Pharmas sleep disorder drug gets European panel backing

Jazz Pharmaceuticals Plcs treatment for a form of sleep disorder has been recommended for approval in Europe by a panel of the…

European advisory group backs Jazz Pharmas solriamfetol

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Jazz Pharmaceuticals Receives Positive CHMP Opinion for Solriamfetol to Improve Wakefulness and Reduce Excessive Daytime Sleepiness in Adults with Narcolepsy or Obstructive Sleep Apnea

DUBLIN , Nov. 15, 2019 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that…

Jazz Pharmaceuticals Announces Participation at Upcoming Investor Conferences

DUBLIN , Nov. 14, 2019 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced…

Are Investors Undervaluing Jazz Pharmaceuticals (JAZZ) Right Now-

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to…

Jazz Pharma (JAZZ) Q3 Earnings Beat, Xyrem Drives Sales

Jazz Pharmaceuticals (JAZZ) beats third-quarter 2019 earnings and revenue estimates and raises its guidance for 2019....…

Jazz Pharmaceuticals plc (JAZZ) CEO Bruce Cozadd on Q3 2019 Results - Earnings Call Transcript

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Jazz Pharmaceuticals Announces Third Quarter 2019 Financial Results

DUBLIN , Nov. 5, 2019 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced financial…

Zacks.com featured highlights include: Koppers, Alaska Air, Guess-, Lionsgate and Jazz Pharmaceuticals

Zacks.com featured highlights include: Koppers, Alaska Air, Guess?, Lionsgate and Jazz Pharmaceuticals...…

Jazz Pharmaceuticals to Report 2019 Third Quarter Financial Results on November 5, 2019

DUBLIN , Oct. 22, 2019 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that…

Enrollment underway in mid-stage study of Jazz Pharmas defibrotide

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Jazz Pharmaceuticals Announces First Patient Enrolled in Phase 2 Clinical Trial Evaluating Defibrotide for the Prevention of CAR-T Associated Neurotoxicity

DUBLIN , Oct. 10, 2019 /PRNewswire/ --   Jazz Pharmaceuticals…

Jazz Pharmaceuticals stock price target raised to $182 from $175 at SVB Leerink

Um den gesamten Artikel unter marketwatch.com zu lesen, klicken Sie bitte auf die Überschrift...…

Jazz Pharmaceuticals Survey Highlights Prevalence of Misinformation and Misperception About Narcolepsy Among Americans

DUBLIN , Sept. 30, 2019 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced the…

Jazz Pharmaceuticals Presents Positive JZP-258 Phase 3 Study Data at World Sleep 2019

DUBLIN , Sept. 25, 2019 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) announced today that positive data from the Phase…

Is Jazz Pharmaceuticals (JAZZ) a Great Value Stock Right Now-

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to…

Jazz Pharmaceuticals Has Good News on Narcolepsy Drug, Analyst Says

Um den gesamten Artikel unter marketwatch.com zu lesen, klicken Sie bitte auf die Überschrift...…

Why Investing In Jazz Pharmaceuticals Is A Game Of Musical Chairs

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Should Value Investors Buy Jazz Pharmaceuticals (JAZZ) Stock-

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to…

Jazz Pharmaceuticals Sees Hammer Chart Pattern: Time to Buy-

Jazz Pharmaceuticals has been struggling lately, but the selling pressure may be coming to an end soon....…

Jazz Pharmaceuticals Announces Participation in Two Upcoming Investor Conferences

DUBLIN , Aug. 27, 2019 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that…

10 Biggest Price Target Changes For Wednesday

Piper Jaffray lowered Jazz Pharmaceuticals PLC (NASDAQ: JAZZ) price target from $205 to $142. Jazz Pharmaceuticals shares closed at…

Is Jazz Pharmaceuticals (JAZZ) a Profitable Value Stock-

Jazz Pharmaceuticals (JAZZ) stock may be a good choice for value-oriented investors right now from multiple angles....…

Jazz Pharmaceuticals buys biotechnology firm Cavion for £259m

As per terms of the deal, the former Cavion shareholders have secured an upfront payment of $52.5m (£43.5m). They are…

Jazz Pharmaceuticals Announces Acquisition of Cavion, Inc.

DUBLIN , Aug. 12, 2019 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced the…

Jazz Pharma (JAZZ) Q2 Earnings and Sales Beat Estimates

Jazz Pharmaceuticals (JAZZ) reports encouraging second-quarter 2019 earnings and revenues and raises its sales guidance for 2019....…